VanEck Genomics and Healthcare Innovators UCITS ETF
UCTCURE
Tracks: MVIS® Global Future Healthcare ESG Index (MVFHCTR)
AUM
USD 14M
nano
TER
0.35%
Currency
USD
Replication
Physical
Inception
2022-09-02
Dividend
Accumulating
Domicile
Ireland
Asset Class
—
Thematic
Classification
Asset ClassEquity
Management StylePassive (Index)
DistributionAccumulating
AUM TierNano (<$50M)
Geographic FocusGlobal
IndexMVIS® Global Future Healthcare ESG Index (MVFHCTR)
Currency TreatmentUnhedged
ReplicationPhysical — Full Replication
Legal StructureUCITS
UCITS EligibleYes
Equity Details
Sectors (GICS)
Health Care
Technology is transforming healthcare. Not only are genomic treatments for several diseases becoming more affordable, but also digitalized healthcare is growing fast. VanEck’s Genomics and Healthcare Innovators UCITS ETF invests in the businesses pioneering ways to treat disease and connect with patients.
as of 2026-08-08
Annual Returns
| Year | Annual |
|---|---|
| 2025 | +17.68% |
| 2024 | -5.13% |
| 2023 | -4.79% |